Shares of Trillium Therapeutics (TRIL) surged when Pfizer (PFE) announced that it would be acquiring shares in TRIL setting it at an astronomical valuation of $2.26 billion or $18.50 per share. Trillium’s portfolio includes biologics that are designed to enhance…
Shares of Microsoft Corporation (MSFT) saw its shares surge 2% today when the company announced some business changes that could impact its bottom line, investors seem to be bullish on the stock. Microsoft announced that it will raise its pricing…
Today is Tesla AI Day, the company’s big recruitment day, with the announcement of the great direction the company is taking. In April of 2019, for the first time ever, Tesla had it’s Autonomy Day event at its head quarters…
A reddit user by the name of Either_Square has revealed some private clients of the Palantir (PLTR) Foundry software. It has revealed that big names companies like Pfizer, General Motors, Comcast, Pepsico, Tyson, NYSE (New York Stock Exchange) and major…
Nio (NIO) reported a successful earnings beat with revenues surging 127%. Nio said it delivered 21,896 vehicles in the second quarter, within its own previously-stated range. For the third quarter, Nio forecasts that it will deliver between 23,000 and 25,000…
Saddle Ranch Media (SRMX) has reported its financial results and Saddle Ranch Media has an operating subsidiary, Tri Cascade, which is an Internet of Things (IoT) technology company focused on providing complete in-home IoT solutions embedded with predictive energy management…
We have been covering Saddle Ranch Media (SRMX) in May, and in August it will be time for the company to release its quarterly earnings report 3 month ended June, 2023. This earnings report will have a bigger picture as…
Popular brokerage Robinhood (HOOD) is slated to open today on its first day of IPO trading. HOOD shares has been priced at $38 valuing the company at $32 billion to the previous $11 billion valuation in private markets. In addition,…
Oragenics (OGEN) is currently developing a next generation COVID vaccine, focused on the creation of the TerraCoV2 immunization product candidate, getting closer toward the goal of accelerating the development of much needed new antibiotics that can work against resistant strains…
Biotech company Tyme Technologies (TYME), who develops cancer metabolism-based therapies announced that it was granted a U.S. Patent for its metabolomic technology platform. The patent, U.S. Patent No. 11,058,638, involves a targeted delivery of therapeutics to cancer cells. Tyme has…
